Search company, investor...

SunTen Phytotech

stpt.com.tw/eng/index.php

Founded Year

2001

Stage

Other Investors | Alive

About SunTen Phytotech

SunTen Phytotech (STPT) develops botanical medicines and functional dietary products with proven efficacy and safety, constructs advanced technical platforms for new botanical drug research and development, and aims to provide CMC services of botanical products. SunTen also aims to provide high quality services in developing bio-medical products.

Headquarters Location

4F.-1, No.268, Liancheng Road Jhonghe City

Taiwan

Missing: SunTen Phytotech's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: SunTen Phytotech's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest SunTen Phytotech News

Lumosa Therapeutics Co Ltd 6535 Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 17082017 Prices from USD $250

Oct 14, 2017

Summary Lumosa Therapeutics Co Ltd Lumosa Therapeutics, formerly SunTen Phytotech Co Ltd is a developer of neurological and inflammatory drugs. The company's pipeline products comprise LT1001 for moderate to severe pain , LT2001 for tumor and cancer and LT3001 for acute ischemic stroke . Its activities comprise translational research, preclinical, intellectual property regulatory affairs, clinical development, project management and business development. Lumosa Therapeutics' products are used in the areas of neural, hypertension, diabetic foot ulcer, oncology and inflammatory diseases. The company partners with biotech and pharmaceutical companies for product licensing, development and commercialization. Lumosa Therapeutics is headquartered in Taipei, Taiwan. Lumosa Therapeutics Co Ltd 6535 Pharmaceuticals Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Pharma eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News

SunTen Phytotech Frequently Asked Questions (FAQ)

  • When was SunTen Phytotech founded?

    SunTen Phytotech was founded in 2001.

  • What is SunTen Phytotech's latest funding round?

    SunTen Phytotech's latest funding round is Other Investors.

  • Who are the investors of SunTen Phytotech?

    Investors of SunTen Phytotech include Pac-Link Ventures and 3V SourceOne.

  • Who are SunTen Phytotech's competitors?

    Competitors of SunTen Phytotech include Zosano Pharma, Adamas Pharmaceuticals, Stemina Biomarker Discovery, ChanTest, Xcellerex and 12 more.

Compare SunTen Phytotech to Competitors

I
INDENA SPA

Indena is a company dedicated to the identification, development and production of active principles derived from plants, for use in the pharmaceutical, health-food and cosmetics industries. Indena, a privately owned Italian company, has around 700 employees, including 10% dedicated to full-time research, aims to manage cultivation, manufacturing, and distribution operations in more than 40 countries throughout the world. The key to Indena's success is its research, covering: the screening of medicinal plants for their pharmacological benefits; the identification of new active principles; and the development of extraction and purification systems at the cutting-edge of industrial application. The phyto-chemical research is carried out in Indena's own Research Center in Settala, Italy. Indena also co-operates with the world's most prestigious universities and private research institutions in the biological assessment of safety and effectiveness up to clinical phase I. One of the main strategic objectives of the research is the development of new active principles for pharmaceutical applications. This is also an indispensable base for the health-food and cosmetics industries. In the pharmaceutical sector Indena is currently focusing on the development of anti-cancer treatments, following the successes of paclitaxel, as well as on anti-microbial and on anti-viral drugs. Also under study are active principles for the treatment of pathologies and dysfunction of the central nervous system, such as depression, anxiety, impotence, sleep disorders, and algesia. Today Indena is also concentrating its efforts on the industrial production of high-quality standardised active principles derived from plants, which are important ingredients in health food products. In fact, the company produces standardised extracts from edible plants that are traditionally recognised as having therapeutic properties, as well as from plants that have proven pharmacological value. Indena's research and production activities are particularly attentive to plant-based principles that have anti-oxidant properties and are effective in preventing damage caused by free radicals. Backed by over 80 years of botanical experience, the Italian company has developed a plantation network, managed by experts, to supply its research and production centers with officinal plants, while at the same time ensuring bio-diversity and protecting the ecosystem balance from uncontrolled harvesting. Today more than 60% of the raw material used in the manufacturing process comes from cultivation. Indena's decades-long global presence in the plant extraction industry is a guarantee of its in-depth knowledge and understanding of the business, market trends and legal considerations, through constant communication and interaction between the company's experts and the major international regulatory authorities such as WHO, EMEA, and ESCOP, and main pharmacopoeias.

O
Onepharm Research and Development

Onepharm Research and Development offers a product isolated from a medicinal plant, with anti-inflammatory activity

S
Stat Analysis

Stat Analysis is a full-service analytical support laboratory (rapid analytical turnaround times, 24/7 operations, and the ability to analyze large numbers of samples) that aims to serve pharmaceutical, environmental, product safety, industrial hygiene, and health care industries.

G
GRAPP

Grand River Aseptic Pharmaceutical Packaging is a pharmaceutical contract manufacturing organization (CMO) supporting the rapid development of new biomedicines to the clinical stage in the State of Michigan. Grand River APP is the result of an alliance between Van Andel Institute (www.vai.org) and Grand Valley State University, and is operating as a non-profit, state- and federally funded corporation. Grand River APP's first aims to assure that therapeutics are properly distributed into dosage forms for all-important Phase I and Phase II human clinical trials. This process, Fill/Finish and Lyophilization, will be offered broadly to academic, nonprofit, and for-profit organizations in Michigan and across North America for liquid-based drug candidates that require vialing in an FDA-regulated aseptic clean room environment. Typical products envisioned for Grand River APP services include small molecule drugs, peptides, monoclonal antibodies, therapeutic proteins and nano-medicines. As a consequence, however, Grand River APP cannot process cytotoxic/genotoxic or virally-based candidates (e.g. viral vaccines).

T
Total Pharmaceutical Care

Total Pharmaceutical Care, Inc. offers home healthcare and infusion therapy services

O
Occam BioLabs

Occam BioLabs is a company engaged in developing technologies for detection and quantification of biomolecules. The company is focused on three general areas of research and development: design and prototyping of electro-optical devices for analysis of biological samples, developing analytic reagents and kits for emergent biomedical fields, providing expertise services for assay optimization including high-throughput quantification in the pharmaceutical industry.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.